Trinity Bivalacqua, MD, PhD, addresses updates in high-risk BCG-unresponsive NMIBC treatment presented at ASCO 2024.
EP. 1: UPCOMING SERIES: Deep Data Dive: Highlights From ASCO 2024 on the Treatment of High-Risk BCG-Unresponsive NMIBC
Trinity Bivalacqua, MD, PhD, announces an upcoming UroView series highlighting key information presented at ASCO 2024 surrounding treatment of high-risk BCG-unresponsive NMIBC.
Physical function and frailty measures offer distinct insights in patients with bladder cancer
FDA to host advisory committee meeting on UGN-102 for NMIBC
Phase 2 trial launches of (177Lu) rhPSMA-10.1 injection in mCRPC
AUA Advocacy Summit: Medicare payment reform among top priorities